449 related articles for article (PubMed ID: 30586737)
21. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
23. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
24. Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke.
Samai A; Monlezun D; Shaban A; George A; Dowell L; Kruse-Jarres R; Schluter L; El Khoury R; Martin-Schild S
Stroke; 2014 Sep; 45(9):2789-91. PubMed ID: 25028444
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis.
Bittar LF; de Paula EV; Mello TB; Siqueira LH; Orsi FL; Annichino-Bizzacchi JM
Clin Appl Thromb Hemost; 2011 Oct; 17(5):514-8. PubMed ID: 20682599
[TBL] [Abstract][Full Text] [Related]
26. High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene.
Kamphuisen PW; Eikenboom JC; Rosendaal FR; Koster T; Blann AD; Vos HL; Bertina RM
Br J Haematol; 2001 Oct; 115(1):156-8. PubMed ID: 11722428
[TBL] [Abstract][Full Text] [Related]
27. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
Tirado I; Mateo J; Soria JM; Oliver A; Martínez-Sánchez E; Vallvé C; Borrell M; Urrutia T; Fontcuberta J
Thromb Haemost; 2005 Mar; 93(3):468-74. PubMed ID: 15735796
[TBL] [Abstract][Full Text] [Related]
28. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
Federici AB
Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects.
Song J; Chen F; Campos M; Bolgiano D; Houck K; Chambless LE; Wu KK; Folsom AR; Couper D; Boerwinkle E; Dong JF
PLoS One; 2015; 10(8):e0132626. PubMed ID: 26244499
[TBL] [Abstract][Full Text] [Related]
30. Association Between Hemostatic Profile and Migraine: A Mendelian Randomization Analysis.
Guo Y; Rist PM; Sabater-Lleal M; de Vries P; Smith N; Ridker PM; Kurth T; Chasman DI
Neurology; 2021 May; 96(20):e2481-e2487. PubMed ID: 33795393
[TBL] [Abstract][Full Text] [Related]
31. Investigation of a coagulation accelerating factor (CAF) in glomerulonephritis.
Salem HH; Howard MA; Koutts J; Firkin BG
Br J Haematol; 1985 Mar; 59(3):485-96. PubMed ID: 3918561
[TBL] [Abstract][Full Text] [Related]
32. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
33. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic.
Kawasaki T; Kaida T; Arnout J; Vermylen J; Hoylaerts MF
Thromb Haemost; 1999 Feb; 81(2):306-11. PubMed ID: 10064011
[TBL] [Abstract][Full Text] [Related]
34. Elevated plasma factor VIII enhances venous thrombus formation in rabbits: contribution of factor XI, von Willebrand factor and tissue factor.
Sugita C; Yamashita A; Matsuura Y; Iwakiri T; Okuyama N; Matsuda S; Matsumoto T; Inoue O; Harada A; Kitazawa T; Hattori K; Shima M; Asada Y
Thromb Haemost; 2013 Jul; 110(1):62-75. PubMed ID: 23636277
[TBL] [Abstract][Full Text] [Related]
35. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J
Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211
[TBL] [Abstract][Full Text] [Related]
36. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
Hubbard AR; Rigsby P; Barrowcliffe TW
Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
[TBL] [Abstract][Full Text] [Related]
37. Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci.
De Visser MC; Sandkuijl LA; Lensen RP; Vos HL; Rosendaal FR; Bertina RM
J Thromb Haemost; 2003 Aug; 1(8):1771-6. PubMed ID: 12911592
[TBL] [Abstract][Full Text] [Related]
38. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
Zimmerman TS; Voss R; Edgington TS
J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
[TBL] [Abstract][Full Text] [Related]
39. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
[TBL] [Abstract][Full Text] [Related]
40. Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.
Johnsen JM; Auer PL; Morrison AC; Jiao S; Wei P; Haessler J; Fox K; McGee SR; Smith JD; Carlson CS; Smith N; Boerwinkle E; Kooperberg C; Nickerson DA; Rich SS; Green D; Peters U; Cushman M; Reiner AP;
Blood; 2013 Jul; 122(4):590-7. PubMed ID: 23690449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
